{"transactions":[{"id":735980,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:49:47.000Z","date":"2026-06-12","kind":"grant","planned":true,"acquired":true,"shares":9795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date."}],"balance_after":165060,"source":{"system":"sec-edgar","filing":"0001339358-26-000002","document":"form4-06162026_090644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000133935826000002/form4-06162026_090644.xml","form_type":"4"}},{"id":743094,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T23:01:52.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":13300,"derivative":{"exercise_price":12.89,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001193125-26-266233","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526266233/ownership.xml","form_type":"4"}},{"id":743093,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T23:01:52.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":216653,"source":{"system":"sec-edgar","filing":"0001193125-26-266233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526266233/ownership.xml","form_type":"4"}},{"id":758531,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-29T20:30:15.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":20582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":20582,"derivative":{"exercise_price":8.59,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":20582},"source":{"system":"sec-edgar","filing":"0001193125-26-248434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000119312526248434/ownership.xml","form_type":"4"}},{"id":758530,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T20:30:15.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":5093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":21727,"source":{"system":"sec-edgar","filing":"0001193125-26-248434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000119312526248434/ownership.xml","form_type":"4"}},{"id":944470,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T21:05:06.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":9.35,"value":1402500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price."}],"balance_after":207453,"source":{"system":"sec-edgar","filing":"0001193125-26-006288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526006288/ownership.xml","form_type":"4"}},{"id":1107657,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T20:35:09.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":12103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025."}],"balance_after":155265,"source":{"system":"sec-edgar","filing":"0000950170-25-087424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000095017025087424/ownership.xml","form_type":"4"}},{"id":1111603,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:23:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11450,"derivative":{"exercise_price":8.37,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":11450},"source":{"system":"sec-edgar","filing":"0000950170-25-086223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025086223/ownership.xml","form_type":"4"}},{"id":1111602,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:23:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":57453,"source":{"system":"sec-edgar","filing":"0000950170-25-086223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025086223/ownership.xml","form_type":"4"}},{"id":1127342,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T22:30:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":65351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":65351,"derivative":{"exercise_price":2.63,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":65351},"source":{"system":"sec-edgar","filing":"0000950170-25-080447","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000095017025080447/ownership.xml","form_type":"4"}},{"id":1127341,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T22:30:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":16634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":16634,"source":{"system":"sec-edgar","filing":"0000950170-25-080447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000095017025080447/ownership.xml","form_type":"4"}},{"id":1437867,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2024-08-08T13:11:08.000Z","date":"2024-08-06","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":15.16,"expiration_date":"2034-08-06","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-025298","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924025298/rdgdoc.xml","form_type":"4"}},{"id":1472932,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:43:16.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":16048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price of the derivative security of the Stock Option (right to buy) reported on the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025."}],"balance_after":16048,"derivative":{"exercise_price":14.19,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":16048},"source":{"system":"sec-edgar","filing":"0000950170-24-075655","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000095017024075655/ownership.xml","form_type":"4/A","original_submission_date":"2024-06-18"}},{"id":1474869,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:42:33.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":16048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025."}],"balance_after":16048,"derivative":{"exercise_price":9.3469,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":16048},"source":{"system":"sec-edgar","filing":"0000950170-24-074946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000095017024074946/ownership.xml","form_type":"4"}},{"id":1474868,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:42:33.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":10570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest in one installment on June 14, 2025."}],"balance_after":143162,"source":{"system":"sec-edgar","filing":"0000950170-24-074946","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000095017024074946/ownership.xml","form_type":"4"}},{"id":1478960,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:19:29.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":11515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11515,"derivative":{"exercise_price":25.85,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":11515},"source":{"system":"sec-edgar","filing":"0000950170-24-073689","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073689/ownership.xml","form_type":"4"}},{"id":1478959,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:19:29.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":7737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":49453,"source":{"system":"sec-edgar","filing":"0000950170-24-073689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073689/ownership.xml","form_type":"4"}},{"id":1500075,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:31:43.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest on May 23, 2025, subject to the Reporting Person's continued service on such date."}],"balance_after":25070,"derivative":{"exercise_price":27.15,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":25070},"source":{"system":"sec-edgar","filing":"0001551306-24-000109","document":"wk-form4_1716946293.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000155130624000109/wk-form4_1716946293.xml","form_type":"4"}},{"id":1500074,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T01:31:43.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":6176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Issuer common stock underlying restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 23, 2025, subject to the Reporting Person's continued service on such date."}],"balance_after":22693,"source":{"system":"sec-edgar","filing":"0001551306-24-000109","document":"wk-form4_1716946293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000155130624000109/wk-form4_1716946293.xml","form_type":"4"}},{"id":1642756,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2024-02-15T00:03:04.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":7356162,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Vida Ventures, LLC (\"Vida\"). Vida Ventures Advisors, LLC is the investment advisor to Vida. Dr. Arie Belldegrun, Leonard Potter and the Reporting Person are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida, but each disclaims beneficial ownership of the shares held by Vida except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1616348},"source":{"system":"sec-edgar","filing":"0000950170-24-015473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000095017024015473/ownership.xml","form_type":"4"}},{"id":1642755,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Redeemable Convertible Preferred Stock","published_at":"2024-02-15T00:03:04.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":8830901,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Vida Ventures, LLC (\"Vida\"). Vida Ventures Advisors, LLC is the investment advisor to Vida. Dr. Arie Belldegrun, Leonard Potter and the Reporting Person are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida, but each disclaims beneficial ownership of the shares held by Vida except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1940388},"source":{"system":"sec-edgar","filing":"0000950170-24-015473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000095017024015473/ownership.xml","form_type":"4"}},{"id":1642754,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Redeemable Convertible Preferred Stock","published_at":"2024-02-15T00:03:04.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":4401771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Vida Ventures, LLC (\"Vida\"). Vida Ventures Advisors, LLC is the investment advisor to Vida. Dr. Arie Belldegrun, Leonard Potter and the Reporting Person are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida, but each disclaims beneficial ownership of the shares held by Vida except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":967188},"source":{"system":"sec-edgar","filing":"0000950170-24-015473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000095017024015473/ownership.xml","form_type":"4"}},{"id":1642753,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T00:03:04.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":4523924,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Vida Ventures, LLC (\"Vida\"). Vida Ventures Advisors, LLC is the investment advisor to Vida. Dr. Arie Belldegrun, Leonard Potter and the Reporting Person are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida, but each disclaims beneficial ownership of the shares held by Vida except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":4523924,"source":{"system":"sec-edgar","filing":"0000950170-24-015473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000095017024015473/ownership.xml","form_type":"4"}},{"id":1784655,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2023-09-08T19:42:56.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year."}],"balance_after":10000,"derivative":{"exercise_price":16.85,"expiration_date":"2033-09-07","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-23-025484","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025484/rdgdoc.xml","form_type":"4"}},{"id":1821488,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-07-28T22:06:09.000Z","date":"2023-07-26","kind":"grant","planned":false,"acquired":true,"shares":69339,"price":9.54,"value":661494.06,"ownership":{"direct":false,"nature":"by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer"}],"balance_after":69339,"source":{"system":"sec-edgar","filing":"0001437749-23-021073","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923021073/rdgdoc.xml","form_type":"4"}},{"id":1847623,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:50:12.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":29136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 16, 2023 and the shares subject to the option shall vest monthly thereafter through June 16, 2024."}],"balance_after":29136,"derivative":{"exercise_price":7.96,"expiration_date":"2033-06-16","underlying":"Common Stock","underlying_shares":29136},"source":{"system":"sec-edgar","filing":"0001217234-23-000123","document":"wf-form4_168738779929036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723423000123/wf-form4_168738779929036.xml","form_type":"4"}},{"id":1847622,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:50:12.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":18844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 16, 2024."}],"balance_after":132592,"source":{"system":"sec-edgar","filing":"0001217234-23-000123","document":"wf-form4_168738779929036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723423000123/wf-form4_168738779929036.xml","form_type":"4"}},{"id":1852192,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:26:08.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2023 with respect to 6,473 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":6473,"derivative":{"exercise_price":45.2,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6473},"source":{"system":"sec-edgar","filing":"0001209191-23-037873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037873/doc4.xml","form_type":"4"}},{"id":1852191,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:26:08.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":41716,"source":{"system":"sec-edgar","filing":"0001209191-23-037873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037873/doc4.xml","form_type":"4"}},{"id":1876092,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T21:01:38.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":18350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":18350,"derivative":{"exercise_price":38.24,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":18350},"source":{"system":"sec-edgar","filing":"0001628280-23-019974","document":"wf-form4_168513485961695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000162828023019974/wf-form4_168513485961695.xml","form_type":"4"}},{"id":1876091,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T21:01:38.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":4385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Issuer common stock underlying restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":16517,"source":{"system":"sec-edgar","filing":"0001628280-23-019974","document":"wf-form4_168513485961695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000162828023019974/wf-form4_168513485961695.xml","form_type":"4"}},{"id":2058607,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T22:27:39.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":1062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":113748,"source":{"system":"sec-edgar","filing":"0001217234-23-000011","document":"wf-form4_167330324497335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723423000011/wf-form4_167330324497335.xml","form_type":"4"}},{"id":2131533,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-26T21:36:22.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":1460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued to the Reporting Person in lieu of annual retainers for board and committee service. The shares underlying the option reflect the payment in full of the Reporting Person's annual retainers of $29,038.20."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":1460,"derivative":{"exercise_price":38.22,"expiration_date":"2032-10-23","underlying":"Common Stock","underlying_shares":1460},"source":{"system":"sec-edgar","filing":"0001628280-22-027102","document":"wf-form4_166682016685550.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000162828022027102/wf-form4_166682016685550.xml","form_type":"4"}},{"id":2131532,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-26T21:36:22.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":15660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":15660,"derivative":{"exercise_price":38.22,"expiration_date":"2032-10-23","underlying":"Common Stock","underlying_shares":15660},"source":{"system":"sec-edgar","filing":"0001628280-22-027102","document":"wf-form4_166682016685550.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000162828022027102/wf-form4_166682016685550.xml","form_type":"4"}},{"id":2131531,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T21:36:22.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":3480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Issuer common stock underlying restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":12132,"source":{"system":"sec-edgar","filing":"0001628280-22-027102","document":"wf-form4_166682016685550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000162828022027102/wf-form4_166682016685550.xml","form_type":"4"}},{"id":2143961,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T21:40:03.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":112686,"source":{"system":"sec-edgar","filing":"0001217234-22-000173","document":"wf-form4_166491958892636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723422000173/wf-form4_166491958892636.xml","form_type":"4"}},{"id":2225130,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:10:38.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":7606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 16, 2022 and the shares subject to the option shall vest monthly thereafter through June 16, 2023."}],"balance_after":7606,"derivative":{"exercise_price":20.56,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":7606},"source":{"system":"sec-edgar","filing":"0001217234-22-000125","document":"wf-form4_165584581900882.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723422000125/wf-form4_165584581900882.xml","form_type":"4"}},{"id":2225129,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:10:38.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":4863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 16, 2023."}],"balance_after":111883,"source":{"system":"sec-edgar","filing":"0001217234-22-000125","document":"wf-form4_165584581900882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723422000125/wf-form4_165584581900882.xml","form_type":"4"}},{"id":2229941,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T22:22:19.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":7688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2022 with respect to 7,688 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":7688,"derivative":{"exercise_price":38.49,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":7688},"source":{"system":"sec-edgar","filing":"0001209191-22-037590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037590/doc4.xml","form_type":"4"}},{"id":2229940,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T22:22:19.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":5197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":37291,"source":{"system":"sec-edgar","filing":"0001209191-22-037590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037590/doc4.xml","form_type":"4"}},{"id":2235930,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T19:37:08.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year."}],"balance_after":10000,"derivative":{"exercise_price":7.06,"expiration_date":"2032-06-08","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-22-014772","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774922014772/rdgdoc.xml","form_type":"4"}},{"id":2534424,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-26T21:40:43.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":15831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":15831,"derivative":{"exercise_price":63.21,"expiration_date":"2026-10-23","underlying":"Common Stock","underlying_shares":15831},"source":{"system":"sec-edgar","filing":"0001179110-21-009630","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000117911021009630/edgar.xml","form_type":"4"}},{"id":2534423,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-26T21:40:43.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":2652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Issuer common stock underlying restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":8652,"source":{"system":"sec-edgar","filing":"0001179110-21-009630","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000117911021009630/edgar.xml","form_type":"4"}},{"id":2654774,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-25T21:56:15.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":3382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 23, 2021 with respect to 3,382 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":3382,"derivative":{"exercise_price":83.59,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":3382},"source":{"system":"sec-edgar","filing":"0001209191-21-043362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121043362/doc4.xml","form_type":"4"}},{"id":2654773,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-25T21:56:15.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":2094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":2094,"source":{"system":"sec-edgar","filing":"0001209191-21-043362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121043362/doc4.xml","form_type":"4"}},{"id":2660441,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T23:56:39.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":1812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 16, 2021 and the shares subject to the option shall vest monthly thereafter through June 16, 2022."}],"balance_after":1812,"derivative":{"exercise_price":88.7,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":1812},"source":{"system":"sec-edgar","filing":"0001217234-21-000140","document":"wf-form4_162431978106643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723421000140/wf-form4_162431978106643.xml","form_type":"4"}},{"id":2660440,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T23:56:39.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":1127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 16, 2022."}],"balance_after":107020,"source":{"system":"sec-edgar","filing":"0001217234-21-000140","document":"wf-form4_162431978106643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723421000140/wf-form4_162431978106643.xml","form_type":"4"}},{"id":2675682,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-09T17:45:03.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year."}],"balance_after":10000,"derivative":{"exercise_price":17.98,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-039136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121039136/doc4.xml","form_type":"4"}},{"id":2899304,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T21:22:35.000Z","date":"2021-01-20","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 22,166 shares as of January 20, 2021."}],"balance_after":18000,"derivative":{"exercise_price":13.78,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-004866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121004866/doc4.xml","form_type":"4"}},{"id":2899303,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-22T21:22:35.000Z","date":"2021-01-20","kind":"exercise","acquired":true,"shares":20000,"price":13.78,"value":275600.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-21-004866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121004866/doc4.xml","form_type":"4"}},{"id":2915008,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-07T01:37:02.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vested on July 20, 2018 and the remaining shares subject to the option vested monthly thereafter through June 20, 2019."}],"balance_after":0,"derivative":{"exercise_price":14.74,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001217234-21-000014","document":"wf-form4_160998340713446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723421000014/wf-form4_160998340713446.xml","form_type":"4"}},{"id":2915007,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:37:02.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":15000,"price":14.74,"value":221100.0,"ownership":{"direct":true},"balance_after":105893,"source":{"system":"sec-edgar","filing":"0001217234-21-000014","document":"wf-form4_160998340713446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723421000014/wf-form4_160998340713446.xml","form_type":"4"}},{"id":2970981,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T21:46:06.000Z","date":"2020-10-24","kind":"grant","acquired":true,"shares":1845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment to the Form 4 filed on October 27, 2020 corrects the number shares underlying the Option that was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of payment of 50% of the Reporting Person's annual retainers for board and committee chair service of $50,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":1845,"derivative":{"exercise_price":27.95,"expiration_date":"2030-10-23","underlying":"Common Stock","underlying_shares":1845},"source":{"system":"sec-edgar","filing":"0001209191-20-059679","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000120919120059679/doc4a.xml","form_type":"4/A","original_submission_date":"2020-10-27"}},{"id":2999209,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-27T21:52:21.000Z","date":"2020-10-24","kind":"grant","acquired":true,"shares":894,"price":27.95,"value":24987.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued to the Reporting Person in lieu of annual retainers for board and committee chair service. The shares underlying the option reflect the payment of 50% of the Reporting Person's annual retainers of $50,000. The Reporting Person received the remaining $25,000 in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":894,"derivative":{"exercise_price":27.95,"expiration_date":"2030-10-23","underlying":"Common Stock","underlying_shares":894},"source":{"system":"sec-edgar","filing":"0001209191-20-055953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000120919120055953/doc4.xml","form_type":"4"}},{"id":2999208,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-27T21:52:21.000Z","date":"2020-10-24","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":27000,"derivative":{"exercise_price":27.95,"expiration_date":"2030-10-23","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-20-055953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000120919120055953/doc4.xml","form_type":"4"}},{"id":2999207,"issuer":{"id":4521,"kind":"organization","name":"Progyny, Inc.","symbol":"PGNY"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-27T21:52:21.000Z","date":"2020-10-24","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Issuer common stock underlying restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-055953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000120919120055953/doc4.xml","form_type":"4"}},{"id":3002699,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-10-20T21:40:07.000Z","date":"2020-10-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-20-021350","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000143774920021350/rdgdoc.xml","form_type":"4"}},{"id":3002698,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-20T21:40:07.000Z","date":"2020-10-19","kind":"exercise","acquired":true,"shares":10000,"price":7.6,"value":76000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-20-021350","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000143774920021350/rdgdoc.xml","form_type":"4"}},{"id":3024791,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-23T01:14:16.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":9745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the shares subject to the option vested on August 1, 2016 and the remaining shares subject to the option vested monthly thereafter through July 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":4.95,"expiration_date":"2026-07-15","underlying":"Common Stock","underlying_shares":9745},"source":{"system":"sec-edgar","filing":"0001217234-20-000164","document":"wf-form4_160082364031692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723420000164/wf-form4_160082364031692.xml","form_type":"4"}},{"id":3024790,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-23T01:14:16.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":6679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested in three equal installments based upon the Issuer's achievement of certain performance goals as follows: (i) one third vest upon the Issuer's determination, which has been reviewed by the Issuer's independent registered public accounting firm, that the Issuer has achieved $10 million of total cumulative sales of Allosure, its proprietary next-generation sequencing-based test to detect donor-derived, cell-free DNA after transplantation, commencing after the completion of the offer by the Issuer to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended, and supplemented on October 24, 2017 and November 9, 2017 (the \"Exchange Offer\"), (ii) one third vest upon the Issuer's determination,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from Footnote 1) which has been reviewed by the Issuer's independent registered public accounting firm, that the Issuer has achieved quarterly revenues of at least $18.75 million for two consecutive fiscal quarters commencing after the completion of the Exchange Offer, and (iii) one third vest in the event the closing sales price of the Issuer's common stock is at or above $5.00 per share, as quoted by NASDAQ, for 10 consecutive trading days after the completion of the Exchange Offer."}],"balance_after":0,"derivative":{"exercise_price":5.49,"expiration_date":"2024-11-09","underlying":"Common Stock","underlying_shares":6679},"source":{"system":"sec-edgar","filing":"0001217234-20-000164","document":"wf-form4_160082364031692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723420000164/wf-form4_160082364031692.xml","form_type":"4"}},{"id":3024789,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T01:14:16.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":9745,"price":4.95,"value":48237.75,"ownership":{"direct":true},"balance_after":90893,"source":{"system":"sec-edgar","filing":"0001217234-20-000164","document":"wf-form4_160082364031692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723420000164/wf-form4_160082364031692.xml","form_type":"4"}},{"id":3024788,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T01:14:16.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":6679,"price":5.49,"value":36667.71,"ownership":{"direct":true},"balance_after":81148,"source":{"system":"sec-edgar","filing":"0001217234-20-000164","document":"wf-form4_160082364031692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723420000164/wf-form4_160082364031692.xml","form_type":"4"}},{"id":3104077,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-20T01:16:55.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":4978,"price":31.35,"value":156060.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 18, 2020 and the shares subject to the option shall vest monthly thereafter through June 18, 2021."}],"balance_after":4978,"derivative":{"exercise_price":31.35,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":4978},"source":{"system":"sec-edgar","filing":"0001217234-20-000100","document":"wf-form4_159261579409511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723420000100/wf-form4_159261579409511.xml","form_type":"4"}},{"id":3104076,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-20T01:16:55.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 18, 2021."}],"balance_after":74469,"source":{"system":"sec-edgar","filing":"0001217234-20-000100","document":"wf-form4_159261579409511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723420000100/wf-form4_159261579409511.xml","form_type":"4"}},{"id":3104329,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-19T21:13:08.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 18, 2020 with respect to 19,000 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":19000,"derivative":{"exercise_price":20.72,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-20-037992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919120037992/doc4.xml","form_type":"4"}},{"id":3114835,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-10T22:38:17.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year."}],"balance_after":10000,"derivative":{"exercise_price":28.24,"expiration_date":"2030-06-07","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-035678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120035678/doc4.xml","form_type":"4"}},{"id":3115949,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-09T20:45:17.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier.  In addition, the option vests in full in the event of a change in control of the Company."}],"balance_after":10000,"derivative":{"exercise_price":26.3,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001384101-20-000093","document":"wf-form4_159173550019404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410120000093/wf-form4_159173550019404.xml","form_type":"4"}},{"id":3142293,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T20:04:44.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":4153,"price":27.5068,"value":114235.7404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $27.47 to $27.60.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001384101-20-000070","document":"wf-form4_158991866706680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410120000070/wf-form4_158991866706680.xml","form_type":"4"}},{"id":3142292,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T20:04:44.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":35847,"price":26.7894,"value":960319.6218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average sales price.  Sale prices for the transactions range from $26.41 to $27.36.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":4153,"source":{"system":"sec-edgar","filing":"0001384101-20-000070","document":"wf-form4_158991866706680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410120000070/wf-form4_158991866706680.xml","form_type":"4"}},{"id":3371695,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":6583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Disposed of in connection with the Merger, whereby such Issuer restricted stock unit award, whether or not vested, was cancelled in exchange for a cash payment of $39,074 and 640 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019. Pursuant to the applicable option award agreement, 100% of the unvested options held by the Reporting Person became fully vested following the change in control of the Issuer effected by the Merger."}],"balance_after":0,"derivative":{"exercise_price":52.41,"exercise_date":"2020-06-14","expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":6583},"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371694,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $62,196 and 1,018 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":51.72,"exercise_date":"2019-06-07","expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371693,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $145,268 and 2,379 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":31.53,"exercise_date":"2018-06-16","expiration_date":"2027-06-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371692,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $167,281 and 2,739 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":26.18,"exercise_date":"2017-06-10","expiration_date":"2026-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371691,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $19,197 and 314 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":36.04,"exercise_date":"2014-06-07","expiration_date":"2023-06-07","underlying":"Common Stock","underlying_shares":1515},"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371690,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $105,114 and 1,721 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":35.87,"exercise_date":"2014-06-07","expiration_date":"2023-06-07","underlying":"Common Stock","underlying_shares":8250},"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371689,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":6068,"ownership":{"direct":false,"nature":"By the Jane K Cohen Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of in connection with the Merger pursuant to the Merger Agreement, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $166,888 and 2,733 shares of Exact Sciences common stock, having a market value of $79.95 per share, based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371688,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":955,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with the Merger, whereby such Issuer restricted stock unit award, whether or not vested, was cancelled in exchange for a cash payment of $26,277 and 430 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3371687,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T21:46:01.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":68165,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in connection with the acquisition of Issuer (the \"Merger\") by Exact Sciences Corporation (\"Exact Sciences\") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the \"Merger Agreement\"), among Exact Sciences, Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $1,874,586 and 30,703 shares of Exact Sciences common stock, having a market value of $79.95 per share, based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":955,"source":{"system":"sec-edgar","filing":"0001209191-19-056642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056642/doc4.xml","form_type":"4"}},{"id":3398889,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T20:00:19.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":185,"price":67.28,"value":12446.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 955 restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company."}],"balance_after":69120,"source":{"system":"sec-edgar","filing":"0001209191-19-052458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119052458/doc4.xml","form_type":"4"}},{"id":3446731,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.94,"expiration_date":"2027-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446730,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.28,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446729,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.41,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446728,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.19,"expiration_date":"2024-05-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446727,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":true,"shares":10000,"price":7.94,"value":79400.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446726,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":true,"shares":10000,"price":5.28,"value":52800.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446725,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":true,"shares":10000,"price":10.41,"value":104100.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3446724,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T20:17:36.000Z","date":"2019-08-02","kind":"exercise","acquired":true,"shares":10000,"price":13.19,"value":131900.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001384101-19-000102","document":"wf-form4_156503623993677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000102/wf-form4_156503623993677.xml","form_type":"4"}},{"id":3461835,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-15T20:27:51.000Z","date":"2019-07-11","kind":"exercise","acquired":false,"shares":5255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the shares subject to the option vested on July 16, 2016 and 1/12th of the shares subject to the option vested monthly thereafter through June 16, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.02,"expiration_date":"2026-06-16","underlying":"Common Stock","underlying_shares":5255},"source":{"system":"sec-edgar","filing":"0000899243-19-019614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019614/doc4.xml","form_type":"4"}},{"id":3461834,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-15T20:27:51.000Z","date":"2019-07-11","kind":"exercise","acquired":false,"shares":5255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vested on July 17, 2015 and 1/12th of the shares subject to the option vested monthly thereafter through June 17, 2016"}],"balance_after":0,"derivative":{"exercise_price":5.85,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":5255},"source":{"system":"sec-edgar","filing":"0000899243-19-019614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019614/doc4.xml","form_type":"4"}},{"id":3461833,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-15T20:27:51.000Z","date":"2019-07-11","kind":"exercise","acquired":false,"shares":5255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vested on August 21, 2014 and 1/12th of the shares subject to the option vested monthly thereafter through July 21, 2015."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2024-07-21","underlying":"Common Stock","underlying_shares":5255},"source":{"system":"sec-edgar","filing":"0000899243-19-019614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019614/doc4.xml","form_type":"4"}},{"id":3461832,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-15T20:27:51.000Z","date":"2019-07-11","kind":"exercise","acquired":true,"shares":5255,"price":5.02,"value":26380.1,"ownership":{"direct":true},"balance_after":71279,"source":{"system":"sec-edgar","filing":"0000899243-19-019614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019614/doc4.xml","form_type":"4"}},{"id":3461831,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-15T20:27:51.000Z","date":"2019-07-11","kind":"exercise","acquired":true,"shares":5255,"price":5.85,"value":30741.75,"ownership":{"direct":true},"balance_after":66024,"source":{"system":"sec-edgar","filing":"0000899243-19-019614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019614/doc4.xml","form_type":"4"}},{"id":3461830,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-15T20:27:51.000Z","date":"2019-07-11","kind":"exercise","acquired":true,"shares":5255,"price":10,"value":52550.0,"ownership":{"direct":true},"balance_after":60769,"source":{"system":"sec-edgar","filing":"0000899243-19-019614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019614/doc4.xml","form_type":"4"}},{"id":3461828,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-15T20:18:39.000Z","date":"2015-06-17","kind":"grant","acquired":false,"shares":5255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 17, 2015 and 1/12th of the shares subject to the option shall vest monthly thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4."}],"balance_after":5255,"derivative":{"exercise_price":5.85,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":5255},"source":{"system":"sec-edgar","filing":"0000899243-19-019606","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319019606/doc4a.xml","form_type":"4/A","original_submission_date":"2015-06-17"}},{"id":3468686,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T17:50:54.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":212,"price":58.86,"value":12478.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 955 restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company."}],"balance_after":68935,"source":{"system":"sec-edgar","filing":"0001209191-19-041251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119041251/doc4.xml","form_type":"4"}},{"id":3483852,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-19T22:01:58.000Z","date":"2019-06-17","kind":"grant","acquired":true,"shares":4152,"price":38.26,"value":158855.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 17, 2019 and the shares subject to the option shall vest monthly thereafter through June 17, 2020."}],"balance_after":4152,"derivative":{"exercise_price":38.26,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":4152},"source":{"system":"sec-edgar","filing":"0000899243-19-017463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319017463/doc4.xml","form_type":"4"}},{"id":3483851,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T22:01:58.000Z","date":"2019-06-17","kind":"grant","acquired":true,"shares":2613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 17, 2020."}],"balance_after":55514,"source":{"system":"sec-edgar","filing":"0000899243-19-017463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319017463/doc4.xml","form_type":"4"}},{"id":3486471,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-18T17:58:47.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":6583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the options become fully vested in the event of a change in control of the Company."}],"balance_after":6583,"derivative":{"exercise_price":52.41,"exercise_date":"2020-06-14","expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":6583},"source":{"system":"sec-edgar","filing":"0001209191-19-037782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119037782/doc4.xml","form_type":"4"}},{"id":3486470,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-18T17:58:47.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company."}],"balance_after":68723,"source":{"system":"sec-edgar","filing":"0001209191-19-037782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119037782/doc4.xml","form_type":"4"}},{"id":3490998,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":37634,"kind":"person","name":"Cohen Fred E","position":1,"cik":"0001339358","reported_name":"Cohen Fred E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-13T20:40:45.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier.  In addition, the option vests in full in the event of a change in control of the Company."}],"balance_after":10000,"derivative":{"exercise_price":27.01,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001384101-19-000074","document":"wf-form4_156045843005070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339358/000138410119000074/wf-form4_156045843005070.xml","form_type":"4"}}],"next_cursor":"2019-06-13T20:40:45.000000Z,3490998"}